Sage Journals: Discover world-class research

Open access

Brief report

First published 2021-10

Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study

Hans-Christoph Diener, Messoud Ashina, Shannon Ritter [...]

Cephalalgia

Open access

Research article

First published 2023-5

Defining migraine days,based on longitudinal E-diary data

Britt W. H. van der Arend, Iris E. Verhagen, Matthijs van Leeuwen [...]

Cephalalgia

Open access

Research article

First published 2022

Rimegepant 75 mg for acute treatment of migraine is associated with significant reduction in monthly migraine days: Results from a long-term,open-label study

Gilbert L’Italien, Evan Popoff, Karissa Johnston [...]

Cephalalgia Reports

Free access

Research article

First published 2005-7

Migraine Days Decline with Duration of Illness in Adolescents with Transformed Migraine

ME Bigal, FD Sheftell, SJ Tepper [...]

Cephalalgia

Open access

Research article

First published 2025-11

What's a migraine day? Analysis of the variety in the definition of a migraine day across phase III trials with drugs targeting the CGRP pathway

Luna De Loose, Koen Paemeleire, Peter J. Goadsby [...]

Cephalalgia

Free access

Research article

First published 2017-2

When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month

M Torres-Ferrús, M Quintana, J Fernandez-Morales [...]

Cephalalgia

Free access

Research article

First published 2014-4

Comparing patient and parent recall of 90-day and 30-day migraine disability using elements of the PedMIDAS and an Internet headache diary

Geoffrey L Heyer, Sara Q Perkins, Sean C Rose [...]

Cephalalgia

Open access

Research article

First published 2023-9

Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study

Britt W. H. van der Arend, Mirthe M. Bloemhof, Alle G. van der Schoor [...]

Cephalalgia

Free access

Research article

First published 2007-7

Topiramate Reduces Headache Days in Chronic Migraine: A Randomized,Double-Blind,Placebo-Controlled Study

H-C Diener, G Bussone, JC Van Oene [...]

Cephalalgia

Open access

Research article

First published 2021-10

Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study

Andreas R Gantenbein, Reto Agosti, Claudio Gobbi [...]

Cephalalgia

Search results